BIOSENSE WEBSTER INC OPTRELL MAPPING CATHETER WITH TRUEREF TECHNOLOGY; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING
|
Back to Search Results |
|
Catalog Number D142901 |
Device Problem
Coagulation in Device or Device Ingredient (1096)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 12/26/2023 |
Event Type
malfunction
|
Event Description
|
It was reported that a patient underwent a cardiac ablation procedure with a optrell mapping catheter with trueref technology and a thrombus was found to be adhered to the outside of the tip.After mapping in rvot, thrombus was found to be adhered to the outside of the tip of optrell.Pressure dripping was performed.Activated clotting time (act) measurement was performed again.Act was 182 after sheath insertion and 268 at mapping after heparin 3000 intravenous injection.It was discussed that thrombus formation may have done due to act that was even less than 300.No error messages were presented and issue was found before ablation was done.The patient has not exhibited any neurological symptoms since the procedure was completed.
|
|
Manufacturer Narrative
|
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
|
Manufacturer Narrative
|
It was reported that a patient underwent a cardiac ablation procedure with a optrell mapping catheter with trueref technology and a thrombus was found to be adhered to the outside of the tip.After mapping in rvot, thrombus was found to be adhered to the outside of the tip of optrell.Pressure dripping was performed.Activated clotting time (act) measurement was performed again.Act was 182 after sheath insertion and 268 at mapping after heparin 3000 intravenous injection.It was discussed that thrombus formation may have done due to act that was even less than 300.Device investigation details: an analysis of the product could not be performed since a physical sample was not received for evaluation.However, if the product is received at a later date, the investigation will be updated as applicable.A manufacturing record evaluation was performed for the finished device 31175178m number, and no internal action related to the complaint was found during the review.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
|
Search Alerts/Recalls
|
|
|